Why the Certificate of Analysis Is Your First Line of Quality Control
When a research peptide arrives in your laboratory, the Certificate of Analysis (COA) is the single most important document accompanying it. Before any compound touches a buffer, a cell lysate, or a binding assay, the COA tells you whether the material you received matches what was ordered, how pure it is, and how it was analytically confirmed. Misreading—or ignoring—a COA can introduce systematic error that invalidates entire experimental runs. This guide walks through every major section of a peptide COA so you can evaluate it critically and reproduce that evaluation for every shipment.
Identifying Information: Confirm Before You Open the Vial
The top section of any COA contains product identification fields. These seem routine, but they deserve careful scrutiny:
- Peptide name and sequence: Verify the single-letter or three-letter amino acid sequence matches your purchase order exactly. A single transposition—for example, Ala-Gly versus Gly-Ala—produces a chemically distinct molecule with potentially different biological activity in your assay.
- Catalog or lot number: The lot number links this specific batch to all analytical data on the document. Keep it in your lab notebook alongside your experimental records for full traceability.
- Molecular formula and molecular weight: Cross-reference these against a peptide calculator or published literature. Discrepancies can flag synthesis errors or incorrect counterion accounting (more on that below).
- Modifications: Note any stated modifications—N-terminal acetylation, C-terminal amidation, disulfide bridges, fluorescent tags, or PEGylation. Each modification shifts the expected mass and should be reflected in the MS data further down the document.
Purity: Understanding the HPLC Trace
Purity is typically determined by reverse-phase high-performance liquid chromatography (RP-HPLC) and expressed as an area percentage at a defined UV absorbance wavelength, most commonly 214 nm or 220 nm. These wavelengths detect the peptide bond backbone rather than aromatic side chains, giving a more representative signal across sequences that lack tryptophan or tyrosine.
A COA from a reputable supplier will include either the raw chromatogram image or a table summarizing retention time and peak area. Key things to assess:
- Reported purity percentage: Common research-grade tiers are >90%, >95%, and >98%. Higher purity is important for structure-activity relationship (SAR) studies, receptor binding experiments, and enzymatic assays where minor impurities could act as competitive inhibitors or ligands in their own right.
- Number and size of impurity peaks: A single main peak with several small shoulders is a different risk profile than a main peak with one large co-eluting impurity at 5%. Examine the chromatogram—not just the headline number—when it is provided.
- Gradient conditions: Some COAs specify the mobile phase gradient used. Shallow gradients resolve more peaks and give a more conservative purity estimate; steep gradients can co-elute structurally related impurities, artificially inflating apparent purity.
Mass Spectrometry: Confirming Molecular Identity
HPLC purity alone cannot confirm molecular identity—a co-eluting compound of similar hydrophobicity could appear as a single peak. Mass spectrometry (MS), typically electrospray ionization (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI-MS), provides the complementary identity confirmation.
On the COA, look for:
- Theoretical monoisotopic or average mass: The document should state which mass type is reported. Monoisotopic mass uses the mass of the most abundant isotope of each element; average mass uses the weighted natural isotopic distribution. For peptides above roughly 2,000 Da, average mass is more practically useful because the monoisotopic peak becomes vanishingly small relative to the isotope envelope.
- Observed m/z and charge state: ESI-MS produces multiply charged ions. A peptide of 3,000 Da detected as a [M+3H]³⁺ ion appears at approximately m/z 1,001. The COA should report both the observed m/z and the calculated mass derived from it, along with the assigned charge state. Confirm the arithmetic yourself when identity is critical.
- Mass accuracy: A well-calibrated instrument should achieve mass accuracy within ±0.1 Da (average mass) or within a few ppm (high-resolution instruments). Large deviations suggest instrument miscalibration, incorrect sequence assignment, or unanticipated modifications.
- Common mass shifts to recognize: +16 Da suggests oxidation of methionine; +80 Da points to phosphorylation; −17 Da or −18 Da may indicate deamidation or water loss. These are useful diagnostic signals if the observed mass deviates from theoretical.
Counterion and Salt Form: A Frequently Overlooked Field
Synthetic peptides are typically supplied as trifluoroacetate (TFA) salts because TFA is the standard ion-pairing agent in RP-HPLC purification. The COA should specify the counterion or salt form. This matters for two practical reasons:
- Net peptide content: TFA contributes mass but no biological activity. A vial labeled as containing 5 mg of peptide may contain significantly less than 5 mg of free-base peptide if counterion mass is not accounted for. Some suppliers report net peptide content separately using methods such as quantitative amino acid analysis (AAA).
- Assay interference: TFA can be cytotoxic at higher concentrations in cell-based assays. COAs for cell-biology applications ideally note whether TFA has been exchanged for acetate or another biocompatible counterion.
Additional Analytical Tests Sometimes Included
Depending on the supplier and peptide application, a COA may include supplementary data:
- Amino acid analysis (AAA): Acid hydrolysis followed by chromatographic quantitation of individual amino acids. AAA provides an orthogonal identity check and can establish actual peptide content independent of weight.
- Water content (Karl Fischer titration): Lyophilized peptides absorb atmospheric moisture. If net peptide content adjusted for water is not reported, researchers should factor in typical moisture levels (often 5–15%) when preparing stock solutions.
- Endotoxin testing: Relevant primarily for in vivo animal studies. The limulus amebocyte lysate (LAL) test or recombinant factor C assay quantifies lipopolysaccharide contamination. This field is not universally present but is critical for immunological research.
- Sterility: For aseptic in vivo work, sterility testing data may be appended. Absence of this field does not imply sterility.
Interpreting COA Data in the Context of Your Experiment
No COA metric exists in a vacuum. A 90% pure peptide may be entirely appropriate for a preliminary competition binding screen but wholly inadequate for crystallography or NMR studies where trace impurities can distort structural data. Similarly, a mass that is confirmed to ±0.5 Da is sufficient for most functional assays but may be insufficient if you are using the peptide as an internal standard for quantitative proteomics.
Build a habit of filing COAs systematically—digitally indexed by lot number—alongside your experimental records. Regulatory and reproducibility considerations increasingly require that published research be traceable to specific reagent lots with documented analytical characteristics. If a supplier cannot provide a COA, or provides one without mass spectrometric data, that is a meaningful quality signal in itself.
When ordering replacement lots for a long-running study, compare the new COA directly against the original. Changes in purity tier, counterion, or observed mass between lots can introduce variables that confound longitudinal data if not caught and documented before use.
For research use only. The information provided in this article is intended solely for use by qualified laboratory researchers in non-clinical research settings. Research peptides supplied by Pepitiva Biolabs are not approved for human or veterinary therapeutic use, and no content herein constitutes medical, clinical, or dosing guidance of any kind.